C000220943 Performance — BlackRock LifePath ESG Index 2035 Fund, Class K
Data updated: 2026-09-25
C000220943 returned +7.38% year to date and +15.15% over one year to Jul 2026. Annualised returns are +12.58% over 3 years and +6.61% over 5 years. The fund trailed its Target-Date category average: $100 invested three years ago grew to $143, against $146 for the category, and to $115 over one year, against $116. Volatility over the past three years was 9.60% a year. In the 12 months to Jul 2026 the fund took in a net $4.2M, and assets reached $17.95M.
C000220943 Growth of $100
What $100 invested in BlackRock LifePath ESG Index 2035 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | C000220943 | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $115 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $143 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $138 | $142 |
| Since data start (Aug 2020 – Jul 2026) | $169 | $174 |
C000220943 Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.38% |
| 1 year | +15.15% |
| 3 years (annualised) | +12.58% |
| 5 years (annualised) | +6.61% |
C000220943 Annual Returns
Calendar-year total returns of BlackRock LifePath ESG Index 2035 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +7.38% |
| 2025 | +15.97% |
| 2024 | +10.93% |
| 2023 | +16.33% |
| 2022 | −17.00% |
| 2021 | +14.75% |
| 2020 (Aug–Dec) | +10.76% |
C000220943 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.1% | +1.6% | −4.6% | +6.0% | +2.9% | +0.1% | −0.6% | — | — | — | — | — |
| 2025 | +2.2% | +0.3% | −2.4% | +0.4% | +3.5% | +3.5% | +0.4% | +2.4% | +2.5% | +1.5% | +0.4% | +0.4% |
| 2024 | −0.2% | +2.2% | +2.5% | −3.3% | +3.6% | +1.5% | +2.4% | +2.1% | +2.0% | −2.5% | +3.2% | −2.7% |
| 2023 | +6.5% | −2.9% | +2.3% | +1.1% | −1.2% | +3.8% | +2.5% | −2.2% | −3.9% | −2.6% | +7.7% | +4.8% |
| 2022 | −4.3% | −2.3% | +0.8% | −6.8% | +0.3% | −6.6% | +6.3% | −4.1% | −8.3% | +4.5% | +6.8% | −3.4% |
| 2021 | −0.3% | +1.8% | +2.2% | +3.3% | +1.5% | +1.0% | +1.1% | +1.7% | −3.3% | +4.0% | −1.9% | +3.0% |
| 2020 | — | — | — | — | — | — | — | +1.2% | −2.3% | −1.8% | +10.0% | +3.7% |
C000220943 Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 9.60%
- 3-year Sharpe ratio: 0.84 (vs 4.5% risk-free rate)
- Best month: +7.68% (Nov 2023)
- Worst month: −4.64% (Mar 2026)
C000220943 Fund Flows
Monthly money in and out of BlackRock LifePath ESG Index 2035 Fund, from SEC Form N-PORT.
- 12-month net flow: $4.2M
- 12-month gross sales (incl. reinvestments): $5.9M
- Sales ÷ redemptions: 3.46×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $196K | $84K | $112K |
| Jun 2026 | $486K | $194K | $292K |
| May 2026 | $452K | $225K | $227K |
| Apr 2026 | $323K | $303K | $20K |
| Mar 2026 | $347K | $367K | −$20K |
| Feb 2026 | $567K | $49K | $518K |
| Jan 2026 | $680K | $111K | $569K |
| Dec 2025 | $479K | $43K | $436K |
| Nov 2025 | $499K | $232K | $267K |
| Oct 2025 | $492K | $17K | $474K |
| Sep 2025 | $148K | $32K | $116K |
| Aug 2025 | $1.2M | $44K | $1.2M |
C000220943 Assets Under Management
Net assets of BlackRock LifePath ESG Index 2035 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $17.95M |
| 2026-04-30 | $16.94M |
| 2026-01-31 | $15.96M |
| 2025-10-31 | $14.54M |
| 2025-07-31 | $11.94M |
| 2025-04-30 | $5.52M |
| 2025-01-31 | $5.15M |
| 2024-10-31 | $4.07M |
| 2024-07-31 | $3.91M |
| 2024-04-30 | $3.51M |
| 2024-01-31 | $3.55M |
| 2023-10-31 | $3.15M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.